Background: The genomic response to adaptation of IMCD3 cells to hypertonicity results in both upregulation and downregulation of a variety of genes. Method: The present study was undertaken to assess the metabonomic and proteomic response of IMCD3 cells that have been chronically adapted to hypertonicity (600 and 900 mosm/kg H2O) as compared to cells under isotonic conditions. Results: Adaptation of IMCD3 cells to hypertonic conditions resulted in a change of a wide range of organic osmolytes, including sorbitol (+8,291%), betaine (+1,099%), myo-inositol (+669%), taurine (+113%) and glycerophosphorylcholine (+61%). Evaluation of the polyol pathway for sorbitol production revealed a reduction in sorbitol dehydrogenase and an increase in aldose reductase mRNA in adapted cells. Proteome analysis revealed increased expression of six glycolytic proteins, including malic enzyme and pyruvate carboxylase, indicating the activation of the pyruvate shunt and changes in glucose metabolism. This study showed that the observed reduction in cell replication could possibly reflect a redirection of cellular energy from cell growth and replication to maintenance of intracellular ion levels in chronically adapted cells. Conclusion: The combined metabonomic and proteomic analysis was shown to be a very helpful tool for the analysis of the effects caused by chronic adaptation to hypertonicity. It made it possible to better evaluate the importance of certain changes that occur in the process of adaptation.

Keywords:
IMCD3 cells, Hypertonicity, Sorbitol, Polyol pathway, Proteomics, Metabonomics
1.
Chamberlin ME, Strange K: Anisosmotic cell volume regulation: a comparative view. Am J Physiol 1989;257:C159–C173.
2.
Garcia-Perez A, Burg MB: Renal medullary organic osmolytes. Physiol Rev 1991;71:1081–1115.
3.
Capasso JM, Rivard CJ, Berl T: Long-term adaptation of renal cells to hypertonicity: role of MAP kinases and Na-K-ATPase. Am J Physiol Renal Physiol 2001;280:F768–F776.
4.
Tian W, Cohen DM: Urea stress is more akin to EGF exposure than to hypertonic stress in renal medullary cells. Am J Physiol Renal Physiol 2002;283:F388–F398.
5.
Rivard CJ, Capasso JM, Heasley LE, Berl T: A genomic analysis of the effects of adaptation to hypertonicity in inner medullary collecting duct (IMCD3) cells (abstract). J Am Soc Nephrol 2003;14:254.
6.
Lindon JC, Holmes E, Nicholson JK: Metabonomics and its role in drug development and disease diagnosis. Expert Rev Mol Diagn 2004;4:189–199.
7.
Floegel U, Willker W, Engelmann J, Niendorf T, Leibfritz D: Adaptation of cellular metabolism to anisosmotic conditions in a glial cell line, as assessed by 13C-NMR spectroscopy. Dev Neurosci 1996;18:449–459.
8.
Lien YH, Shapiro JI, Chan L: Effects of hypernatremia on organic brain osmoles. J Clin Invest 1990;85:1427–1435.
9.
Lien YH, Shapiro JI, Chan L: Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 1991;88:303–309.
10.
Gullans SR, Blumenfeld JD, Balschi JA, Kaleta M, Brenner RM, Heilig CW, Hebert SC: Accumulation of major organic osmolytes in rat renal inner medulla in dehydration. Am J Physiol 1988;255:F626–F634.
11.
Nicholson JK, Connelly J, Lindon JC, Holmes E: Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002;1:153–161.
12.
Cockerell GL, McKim JM, Vonderfecht SL: Strategic importance of research support through pathology. Toxicol Pathol 2002;30:4–7.
13.
Smith LL: Key challenges for toxicologists in the 21st century. Trends Pharmacol Sci 2001;22:281–285.
14.
Reynolds VL: Applications of emerging technologies in toxicology and safety assessment. Int J Toxicol 2005;24:135–137.
15.
Pognan F: Genomics, proteomics and metabonomics in toxicology: hopefully not ‘fashionomics’. Pharmacogenomics 2004;5:879–893.
16.
Pihakaski-Maunsbach K, Tokonabe S, Vorum H, Rivard CJ, Capasso JM, Berl T, Maunsbach AB: The gamma-subunit of Na-K-ATPase is incorporated into plasma membranes of mouse IMCD3 cells in response to hypertonicity. Am J Physiol Renal Physiol 2005;288:F650–F657.
17.
Freeman DM, Hurd R: Decoupling: theory and practice. II. State of the art: in vivo applications of decoupling. NMR Biomed 1997;10:381–393.
18.
Harvey PJ, Gready JE, Hickey HM, Le Couteur DG, McLean AJ: 31P and 1H NMR spectroscopic studies of liver extracts of carbon tetrachloride-treated rats. NMR Biomed 1999;12:395–401.
19.
Wehrli SL, Palmieri MJ, Reynolds RA, Segal S: 31P NMR spectra of intact red blood cells: quantitation of UDPGlucose and UDPGalactose. Magn Reson Med 1993;30:494–497.
20.
Floegel U, Niendorf T, Serkowa N, Brand A, Henke J, Leibfritz D: Changes in organic solutes, volume, energy state, and metabolism associated with osmotic stress in a glial cell line: a multinuclear NMR study. Neurochem Res 1995;20:793–802.
21.
Blake CA, Brown LM, Duncan MW, Hunsucker SW, Helmke SM: Estrogen regulation of the rat anterior pituitary gland proteome. Exp Biol Med (Maywood) 2005;230:800–807.
22.
Rivard CJ, Brown LM, Almeida NE, Maunsbach AB, Pihakaski-Maunsbach K, Andres-Hernando A, Capasso JM, Berl T: Expression of the calcium-binding protein S100A4 is markedly up-regulated by osmotic stress and is involved in the renal osmoadaptive response. J Biol Chem 2007;282:6644–6652.
23.
Schousboe A, Westergaard N, Sonnewald U, Petersen SB, Huang R, Peng L, Hertz L: Glutamate and glutamine metabolism and compartmentation in astrocytes. Dev Neurosci 1993;15:359–366.
24.
Yancey PH, Burg MB: Distribution of major organic osmolytes in rabbit kidneys in diuresis and antidiuresis. Am J Physiol 1989;257:F602–F607.
25.
Yancey PH, Burg MB, Bagnasco SM: Effects of NaCl, glucose, and aldose reductase inhibitors on cloning efficiency of renal medullary cells. Am J Physiol 1990;258:C156–C163.
26.
Yancey PH, Haner RG, Freudenberger TH: Effects of an aldose reductase inhibitor on organic osmotic effectors in rat renal medulla. Am J Physiol 1990;259:F733–F738.
27.
Rivard CJ, Almeida NE, Berl T, Capasso JM: The gamma subunit of Na/K-ATPase: an exceptional, small transmembrane protein. Front Biosci 2005;10:2604–2610.
28.
Kelleher JK, Kelly PJ, Wright BE: Amino acid catabolism and malic enzyme in differentiating Dictyostelium discoideum. J Bacteriol 1979;138:467–474.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.